Literature DB >> 10233940

Molecular requirements for human immunodeficiency virus type 1 plus-strand transfer: analysis in reconstituted and endogenous reverse transcription systems.

T Wu1, J Guo, J Bess, L E Henderson, J G Levin.   

Abstract

We have developed a reconstituted system which models the events associated with human immunodeficiency virus type 1 (HIV-1) plus-strand transfer. These events include synthesis of plus-strand strong-stop DNA [(+) SSDNA] from a minus-strand DNA donor template covalently attached to human tRNA3Lys, tRNA primer removal, and annealing of (+) SSDNA to the minus-strand DNA acceptor template. Termination of (+) SSDNA synthesis at the methyl A (nucleotide 58) near the 3' end of tRNA3Lys reconstitutes the 18-nucleotide primer binding site (PBS). Analysis of (+) SSDNA synthesis in vitro and in HIV-1 endogenous reactions indicated another major termination site: the pseudouridine at nucleotide 55. In certain HIV-1 strains, complementarity between nucleotides 56 to 58 and the first three bases downstream of the PBS could allow all of the (+) SSDNA products to be productively transferred. Undermodification of the tRNA may be responsible for termination beyond the methyl A. In studies of tRNA removal, we find that initial cleavage of the 3' rA by RNase H is not sufficient to achieve successful strand transfer. The RNA-DNA hybrid formed by the penultimate 17 bases of tRNA still annealed to (+) SSDNA must also be destabilized. This can occur by removal of additional 3'-terminal bases by RNase H (added either in cis or trans). Alternatively, the nucleic acid chaperone activity of nucleocapsid protein (NC) can catalyze this destabilization. NC stimulates annealing of the complementary PBS sequences in (+) SSDNA and the acceptor DNA template. Reverse transcriptase also promotes annealing but to a lesser extent than NC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10233940      PMCID: PMC112522     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  74 in total

1.  Evidence for a unique mechanism of strand transfer from the transactivation response region of HIV-1.

Authors:  J K Kim; C Palaniappan; W Wu; P J Fay; R A Bambara
Journal:  J Biol Chem       Date:  1997-07-04       Impact factor: 5.157

2.  Strand displacement synthesis capability of Moloney murine leukemia virus reverse transcriptase.

Authors:  S H Whiting; J J Champoux
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

3.  Role of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.

Authors:  V Tanchou; D Decimo; C Péchoux; D Lener; V Rogemond; L Berthoux; M Ottmann; J L Darlix
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Posttranscriptional modification of retroviral primers is required for late stages of DNA replication.

Authors:  B P Burnett; C S McHenry
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

5.  Characterization of RNA strand displacement synthesis by Moloney murine leukemia virus reverse transcriptase.

Authors:  C D Kelleher; J J Champoux
Journal:  J Biol Chem       Date:  1998-04-17       Impact factor: 5.157

6.  Effects of mutations in the polymerase domain on the polymerase, RNase H and strand transfer activities of human immunodeficiency virus type 1 reverse transcriptase.

Authors:  H Q Gao; P L Boyer; E Arnold; S H Hughes
Journal:  J Mol Biol       Date:  1998-04-03       Impact factor: 5.469

7.  The isolated RNase H domain of murine leukemia virus reverse transcriptase. Retention of activity with concomitant loss of specificity.

Authors:  X Zhan; R J Crouch
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

8.  DNA strand exchange and selective DNA annealing promoted by the human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Z Tsuchihashi; P O Brown
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  The use of DNA and RNA oligonucleotides in hybrid structures with longer polynucleotide chains to probe the structural requirements for moloney murine leukemia virus plus strand priming.

Authors:  C A Randolph; J J Champoux
Journal:  J Biol Chem       Date:  1994-07-29       Impact factor: 5.157

10.  An RNA chaperone activity of non-specific RNA binding proteins in hammerhead ribozyme catalysis.

Authors:  D Herschlag; M Khosla; Z Tsuchihashi; R L Karpel
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  31 in total

1.  Structural determinants of murine leukemia virus reverse transcriptase that affect the frequency of template switching.

Authors:  E S Svarovskaia; K A Delviks; C K Hwang; V K Pathak
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

2.  Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Jianhui Guo; Tiyun Wu; Bradley F Kane; Donald G Johnson; Louis E Henderson; Robert J Gorelick; Judith G Levin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

3.  Zinc finger-dependent HIV-1 nucleocapsid protein-TAR RNA interactions.

Authors:  Nick Lee; Robert J Gorelick; Karin Musier-Forsyth
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

4.  Reduced fitness in cell culture of HIV-1 with nonnucleoside reverse transcriptase inhibitor-resistant mutations correlates with relative levels of reverse transcriptase content and RNase H activity in virions.

Authors:  Jiong Wang; Robert A Bambara; Lisa M Demeter; Carrie Dykes
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

Review 5.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

6.  Single-molecule FRET studies of important intermediates in the nucleocapsid-protein-chaperoned minus-strand transfer step in HIV-1 reverse transcription.

Authors:  Hsiao-Wei Liu; Gonzalo Cosa; Christy F Landes; Yining Zeng; Brandie J Kovaleski; Daniel G Mullen; George Barany; Karin Musier-Forsyth; Paul F Barbara
Journal:  Biophys J       Date:  2005-08-12       Impact factor: 4.033

7.  Tighter binding of HIV reverse transcriptase to RNA-DNA versus DNA-DNA results mostly from interactions in the polymerase domain and requires just a small stretch of RNA-DNA.

Authors:  William P Bohlayer; Jeffrey J DeStefano
Journal:  Biochemistry       Date:  2006-06-20       Impact factor: 3.162

Review 8.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

9.  Impact of human immunodeficiency virus type 1 RNA dimerization on viral infectivity and of stem-loop B on RNA dimerization and reverse transcription and dissociation of dimerization from packaging.

Authors:  N Shen; L Jetté; C Liang; M A Wainberg; M Laughrea
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

10.  Optimal translation initiation enables Vif-deficient human immunodeficiency virus type 1 to escape restriction by APOBEC3G.

Authors:  Guylaine Haché; Truus E M Abbink; Ben Berkhout; Reuben S Harris
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.